Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9006948 | 0.86 | TSHR (0.39) | ACE2USP2CYP3A4SMN1; SMN2LMNA | |
| SCHEMBL8179631 | 0.84 | LMNA (0.39) | ACE2OPRM1USP2CYP3A4SMN1; SMN2 | |
| SCHEMBL28162919 | 0.82 | ACE2 (0.36) | ACE2OPRM1LMNA | |
| SCHEMBL6760264 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL20506756 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL21086628 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL20506768 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL20835139 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL20506761 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB | |
| SCHEMBL9488357 | 0.81 | ACE2 (0.62) | ACE2OPRM1PRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835846-B2 | The present invention provides an aliphatic compound represented by the following formula (I) or pharmacologically acceptable salts thereof: the aliphatic compound being an optical isomer of the (2R,3S,2'S) configuration when the | MARUHA CORPORATION (JP) | 2004-12-28 | — | — | US | disclosed |
| US-20040014816-A1 | Novel aliphatic compounds, process for their preparation and their usage | MARUHA NICHIRO SEAFOODS, INC. (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1325904-A1 | NOVEL ALIPHATIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USAGE | Maruha Corporation (JP) | 2003-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014816-A1 | Novel aliphatic compounds, process for their preparation and their usage | CPT1B, ACSS2, CERS2 | ACE2 1437/4885OPRM1 2653/4885PRKD3 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.